Posted in

COVID-19

Updates to PPE Requirements for Research Staff

In an ongoing effort to reduce the risks of potential exposure to COVID-19, UF Health continues to update guidance on PPE (Personal Protection Equipment) use in patient-care areas. These updates impact the current PPE requirements for UF research staff. Changes and clarifications include the following: At a minimum,…

UF|Research Resumption Plan – Stage 3

The University of Florida has now begun Stage 3 in the process for reengaging on-campus research activities which have been interrupted by the COVID-19 pandemic.

Free Webinar: Considerations for Restarting Research

UF|Research and OCR have each recently provided UF-specific research resumption guidance. The information in this webinar should not to be used to conflict with UF Guidance, but there may be useful information shared that we can all glean something from. Additionally, there are possible CE’s for certain accrediting organizations if there is an interest there.

UF|Research Resumption Plan – Stage 2

The University of Florida has now begun Stage 2 in the process for reengaging on-campus research activities which have been interrupted by the COVID-19 pandemic.

UF Clinical Research Resumption Plan

The UF Office of Clinical Research has published guidance for resuming clinical research projects, which applies to all UF health-related human subjects research.

Shipping of Investigational Drugs

UF Health Investigational Drug Services has developed a position statement on the issue of shipping dispensed Rx to research participants.